FNY Investment Advisers’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-86,305
Closed -$8.37M 1204
2019
Q3
$8.37M Sell
86,305
-27,025
-24% -$2.71M 2.56% 8
2019
Q2
$11.6M Sell
113,330
-166,663
-60% -$18M 3.42% 4
2019
Q1
$31.9M Buy
+279,993
New +$20.6M 10.91% 1

FNY Investment Advisers's ONCE Position: Q4 2019 in Review

FNY Investment Advisers sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 86,305 shares — an estimated $8.37M sold.

FNY Investment Advisers first reported a position in ONCE in Q1 2019 and held it in 3 quarters. The position peaked at $31.9M in Q1 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

  • FNY Investment Advisers reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • FNY Investment Advisers sold 86,305 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $8.37M.
  • FNY Investment Advisers first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2019 and held it in 3 quarters.
  • FNY Investment Advisers's Spark Therapeutics, Inc. Common Stock position peaked at $31.9M in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on FNY Investment Advisers's 13F filing for Q4 2019, filed 10 Jan 2020.